Table of Contents
<< Previous Issue | Jul 2009 (Vol: 2009, Issue: 7) | Next Issue >> |
- Section: Distribution & Marketing
-
NeurogesX and Astellas Enter into Commercialisation Agreement for Pain Patch
- Section: Joint Venture
-
J&J in US$1.5 B Alzheimer’s Pact with Elan
- Section: Licensing
-
Xenon and Merck Collaborate on Cardiovascular Disease Treatment
-
Merck and Portola’s Agreement on Anticoagulant Drug
-
Catalyst Biosciences Signs Two Key Deals
- Section: Mergers & Acquisitions
-
Novartis Buys Ebewe in Oncology Generics Push
-
CombinatoRx and Neuromed Sign Merger Agreement
-
Bristol-Myers Squibb Acquires Medarex
-
Lundbeck Hits Acquisition Trail
-
Hisamitsu’s Expansion in the US
- Section: Research & Development
-
GSK Signs Drug Pact with Chroma Therapeutics
-
Mylan Enters Generic Biologicals Market
-
Gilead Signs Triple Therapy Deal for HIV